SG Americas Securities
MIST icon

SG Americas Securities’s Milestone Pharmaceuticals MIST Stock Holding History

SG Americas Securities’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51K Sell
42,512
-54,863
-56% -$96.1K ﹤0.01% 3023
2025
Q4 		$197K Buy
+97,375
New +$210K ﹤0.01% 2934

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

SG Americas Securities's MIST Position: Q1 2026 in Review

SG Americas Securities reduced its Milestone Pharmaceuticals (MIST) stake by 56% in Q1 2026, selling an estimated $96.1K and leaving 42,512 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

SG Americas Securities first reported a position in MIST in Q4 2025 and has held it in 2 quarters since. The position peaked at $197K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • SG Americas Securities held 42,512 shares of Milestone Pharmaceuticals worth $51K as of Q1 2026.
  • SG Americas Securities sold 54,863 Milestone Pharmaceuticals shares in Q1 2026, an estimated $96.1K.
  • Milestone Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #3023 holding.
  • SG Americas Securities first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • SG Americas Securities's Milestone Pharmaceuticals position peaked at $197K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.